09. 11(Thu)
09. 11(Thu) 13:00~14:30 Room 4
Lipid Metabolism at the Crossroads of Inflammation, Toxicity, and Atherosclerosis
- From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events 13:00~13:20
- Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions 13:20~13:40
- Lipidomics based understanding of human disease 13:40~14:00
- Panel Discussion 14:00~14:30
09. 11(Thu) 14:40~16:10 Room 4
Redefining Cardiovascular Care: PCSK9 Mechanisms and siRNA-based Advances
09. 11(Thu) 16:20~17:50 Room 4
Socioeconomic Status: The Missing Piece in Cardiovascular Risk Stratification
09. 12(Fri)
09. 12(Fri) 08:30~10:00 Room 4
Shaping the Future of Lipid Management: Insights from the New Consensus and Current Dyslipidemia Trends
09. 12(Fri) 13:00~14:30 Room 4
Defining the Optimal LDL-C Target for Prevention of Atherosclerotic Cardiovascular and Cerebrovascular Disease
- Optimal LDL-C goals for secondary prevention in high-risk patients - a cardiologist’s perspective 13:00~13:20
- Optimal LDL-C level for stroke prevention - insights from a neurologist’s perspective 13:20~13:40
- Different LDL-C targets by duration of diabetes: what is the evidence? - an endocrinologist’s perspective 13:40~14:00
- Panel Discussion 14:00~14:30
09. 12(Fri) 16:45~18:15 Room 4
Immunometabolic Programming of Macrophages in Cardiovascular Injury and Repair
09. 13(Sat)
09. 13(Sat) 08:50~10:20 Room 4
From Treatment to Prevention: A Paradigm Shift in Obesity
09. 13(Sat) 14:50~16:20 Room 4
TBD
